- Home
- AXSM vs LOPE Comparison
AXSM vs LOPE Comparison
Compare AXSM & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- LOPE
- Stock Information
- Founded
- AXSM 2012
- LOPE 1949
- Country
- AXSM United States
- LOPE United States
- Employees
- AXSM N/A
- LOPE N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- LOPE Other Consumer Services
- Sector
- AXSM Health Care
- LOPE Real Estate
- Exchange
- AXSM Nasdaq
- LOPE Nasdaq
- Market Cap
- AXSM 4.2B
- LOPE 4.7B
- IPO Year
- AXSM 2015
- LOPE 2008
- Fundamental
- Price
- AXSM $84.60
- LOPE $166.01
- Analyst Decision
- AXSM Strong Buy
- LOPE Buy
- Analyst Count
- AXSM 14
- LOPE 3
- Target Price
- AXSM $125.54
- LOPE $179.67
- AVG Volume (30 Days)
- AXSM 893.5K
- LOPE 129.5K
- Earning Date
- AXSM 02-18-2025
- LOPE 02-11-2025
- Dividend Yield
- AXSM N/A
- LOPE N/A
- EPS Growth
- AXSM N/A
- LOPE 18.90
- EPS
- AXSM N/A
- LOPE 7.64
- Revenue
- AXSM $338,457,000.00
- LOPE $1,018,713,000.00
- Revenue This Year
- AXSM $44.77
- LOPE $9.38
- Revenue Next Year
- AXSM $67.70
- LOPE $6.18
- P/E Ratio
- AXSM N/A
- LOPE $21.65
- Revenue Growth
- AXSM 51.47
- LOPE 8.22
- 52 Week Low
- AXSM $64.11
- LOPE $118.48
- 52 Week High
- AXSM $105.00
- LOPE $173.37
- Technical
- Relative Strength Index (RSI)
- AXSM 43.66
- LOPE 56.45
- Support Level
- AXSM $79.19
- LOPE $159.06
- Resistance Level
- AXSM $87.53
- LOPE $165.06
- Average True Range (ATR)
- AXSM 4.37
- LOPE 2.94
- MACD
- AXSM -0.02
- LOPE -0.21
- Stochastic Oscillator
- AXSM 61.27
- LOPE 98.06
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About LOPE Grand Canyon Education Inc.
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases and certificates across nine colleges both online, on ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.